The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism | Zendy

Inaam A. Nakchbandi | Zendy; Robert Lang | Zendy; Barbara K. Kinder | Zendy; Karl Insogna | Zendy

Open Access

The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism

Author(s) -

Inaam A. Nakchbandi,

Robert Lang,

Barbara K. Kinder,

Karl Insogna

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-1645

Subject(s) - osteoprotegerin , medicine , endocrinology , bone resorption , rankl , bone remodeling , receptor , activator (genetics) , chemistry , deoxypyridinoline , n terminal telopeptide , osteocalcin , alkaline phosphatase , biochemistry , enzyme

The mechanisms of action of PTH on bone in vivo remain incompletely understood. The objective of this investigation was to examine changes in serum levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin (OPG) in primary hyperparathyroidism and their relationship to bone loss.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research